S 1930 · 119th Congress · Health

Small Biotech Innovation Act

Introduced 2025-06-03· Sponsored by Sen. Cassidy, Bill [R-LA]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Finance.(2025-06-03)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 1930 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 1930 To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 3, 2025 Mr. Cassidy introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Small Biotech Innovation Act''. SEC. 2. RESEARCH AND DEVELOPMENT-INTENSIVE SMALL BIOTECH MANUFACTURER EXCEPTION FROM MEDICARE DRUG PRICE NEGOTIATION PROGRAM. Section 1192(d)(2) of the Social Security …

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican